High risk types of human papillomavirus (HPV) are agents in the aetiology of cervical carcinoma. The products of two early genes, E6 and E7, appear to be the principal transforming proteins. Studies of various monolayer cell culture systems have shown that the E7 oncoprotein of human papillomavirus type 16 is able to neutralize or bypass the inhibitory eect of the cell cycledependent kinase (CDK) inhibitors (CKIs) p21
High risk types of human papillomavirus (HPV) are agents in the aetiology of cervical carcinoma. The products of two early genes, E6 and E7, appear to be the principal transforming proteins. Studies of various monolayer cell culture systems have shown that the E7 oncoprotein of human papillomavirus type 16 is able to neutralize or bypass the inhibitory eect of the cell cycledependent kinase (CDK) inhibitors (CKIs) p21 WAF1/CIP1 and p27 KIP1 . To understand whether the p21 WAF1/CIP1 or p27 KIP1 neutralization also plays a role in vivo, we performed studies on clinical specimens. Forty-®ve cervical biopsies, including HPV-negative mucosa, HPV 16-positive preinvasive (low and high grade lesions) and invasive neoplasia as well as HPV 6-positive condyloma acuminatum were analysed by single and double immunohistology. We examined the positive cell cycle regulator cyclin A and the universal cell cycle marker Ki67 as well as the negative cell cycle regulators p21 WAF1/CIP1 and p27 KIP1 . Here, we show that in a signi®cant fraction of cells the G1 block can be overcome despite high levels of CKIs in HPV lesions. This phenomenon, which was more evident for p21 WAF1/CIP1 than for p27 KIP1 was most marked in low grade lesions and in condylomata acuminata, in which a high viral productivity is expected. These results indicate that the overriding of CKI inactivation by viral oncoproteins appears to be a conserved property between low and high risk HPV types. We conclude that the CKI neutraliza
Introduction
Infection with high risk types of human papillomavirus (HPV) constitutes a major risk factor in the development of cervical carcinoma and its precursors (zur Hausen and de Villiers, 1994) . In contrast, low risk HPVs induce benign condylomata and are not usually associated with malignant cervical disease (Gissmann et al., 1982) . HPVs encode two early viral oncoproteins, E6 and E7 (zur Hausen, 1986) . The main eect of these viral oncoproteins is to release the G1 block to ensure viral DNA replication in keratinocytes that are normally quiescent. These cells have retained their dierentiated phenotype, which is essential to support viral transcription of late genes to complete the viral life cycle (Byrne, 1997) . Thus, E6 and E7 oncoproteins have evolved strategies to uncouple cell cycle progression and dierentiation by abrogating restriction point control through interference with cell cycle-associated proteins (Howley, 1996) . E6 binds and inactivates p53 whereas E7 has a similar eect on the pocket protein family comprising the retinoblastoma susceptibility protein (pRB), p107 and p130 (Schener et al., 1990; Dyson et al., 1989; Davies et al., 1993; Hu et al., 1995) . All four proteins are negative regulators of the cell cycle.
Pocket proteins play a key role in controlling the G1/S transition of the cell cycle (Herwig and Strauss, 1997) . Their main function is to bind and inactivate several transcription factors, including the E2F protein family. Dierent members of this family control the transcription of at least two classes of E2F-regulated genes; those that are important for G1/S transition and those that encode proteins required for DNA synthesis (La Thangue, 1994) . The inhibitory function of the pocket proteins is regulated by phosphorylation. Only the hypophosphorylated form of the pocket proteins has the ability to associate with the E2F complexes. The phosphorylation of the pocket proteins is mediated by cyclin-dependent kinases (CDKs) and results in the release of active E2F (Beijersbergen and Bernards, 1996) . This enables the synthesis of proteins involved in cell cycle progression, such as cyclins E and A. Cyclin A is a regulatory component of CDK2, and is important for the progression through S phase and for the transition between G2 and M phases of the cell cycle (Pines, 1995) .
Several ®ndings show that the biological activity of E7 is not exclusively mediated by the interaction with the pocket proteins. E7 can overcome several forms of G1 arrest that are induced by various antiproliferative signals including TGF-b treatment, loss of cell adhesion, or after DNA damage (Demers et al., 1996; Schulze et al., 1998; Hickman et al., 1994) . In vitro studies on monolayer culture systems indicate that these activities are mediated in part by the E7 binding and inactivation of the two related cyclin-dependent kinase (CDK) inhibitors (CKIs) p21 WAF1/CIP1 and p27 al., 1996) . Both CKIs are implicated in various forms of cell cycle arrest preventing the phosphorylation of the pocket proteins through binding to G1 phase cyclin-CDK complexes (Xiong et al., 1993; El-Deiry et al., 1993; Polyak et al., 1994) . The above-mentioned in vitro studies have provided important insights into how the E7 protein can bypass G1 arrest induced by CKIs. However, most of these studies were performed in monolayer culture systems by overexpressing E7 under the control of foreign promoters and were not able to address the behaviour of HPVs in dierentiating cells of a full thickness epithelium. Additionally, it is likely that pathways of the human host including the immune or endocrine system in¯uence HPV-dependent events. Such parameters are not amenable to analysis in in vitro systems.
We investigate whether the inactivation of CKIs by HPV plays a role in vivo. We examined the in vivo localization of positive and negative cell cycle markers in human cervical tissue. Specimens of normal, noninfected tissue, HPV 16-infected lesions ranging from low grade cervical intra-epithelial neoplasia (LCIN) to invasive cervical carcinoma (ICC) and HPV 6-infected condyloma acuminatum were included in the study. Our results demonstrate that in HPV-infected mucosa, a fraction of cells retained the ability to progress into S phase, in spite of containing high levels of CKIs. Additionally, we show that this phenomenon occurs mainly in LCIN as well as in condyloma acuminatum but rarely in high grade CIN (HCIN) and ICC. These data suggest that the overriding of cell cycle-inhibitory signals is a property of human papillomaviral oncoproteins not only in in vitro systems but also in the whole organism. Moreover, we propose that the inactivation of CKIs is a conserved mechanism of low and high risk HPVs alike.
Results
Since the aim of this study was to determine whether the ability of HPV oncoproteins to override the cell cycle inhibitors p21 WAF1/CIP1 and p27 KIP1 has a biological signi®cance in vivo, we analysed the distribution of positive and negative cell cycle regulators in HPVpositive cervical lesions. To establish a normal standard relative to the pattern evolving in the lesions, we also characterized normal cervical mucosa by standard immunohistology using antibodies against cyclin A, p21 WAF1/CIP1 and p27
KIP1
. Cyclin A was chosen as a positive cell cycle marker for two reasons; (i) cyclin A is linked to the cell division cycle and is normally synthesized in late G1 after the cell has passed the restriction point. It is required for the S phase progression as well as for G2/M phase transition (Pines, 1995) WAF1/CIP1 and p27 KIP1 in most human tissues including skin and oral mucosa were subject to precise topological control (El-Deiry et al., 1995; Fredersdorf et al., 1996 Fredersdorf et al., , 1997 . Unlike SchmidtGrimminger et al., we did not detect p21 WAF1/CIP1 in the proliferating compartment of the cervix mucosa (Schmidt-Grimminger et al., 1998).
The compartmentalization of cyclin A and the cyclin-dependent kinase inhibitors p21 WAF1/CIP1 and p27 KIP1 is disrupted in HPV 16-infected neoplastic cervical epithelium
To examine the pattern of positive and negative cell cycle-regulatory proteins in cervical lesions, we performed immunohistology on HPV 16-positive cervical neoplasia with the same markers as above. The specimens included in this study were previously characterized (Zehbe et al., , 1997 and consisted of 7 cases of LCIN, 16 cases of HCIN and 13 cases of ICC of squamous cell type (Table 1) . Additionally, we performed RNA : RNA in situ hybridization for the detection of E6 and E7 transcripts of the specimens diagnosed as LCIN, HCIN and ICC as described in a Figure 2 ). In accordance with the earlier investigation, signal intensity increased strongly in the more dierentiated cells in LCIN. This pattern of viral gene expression most likely re¯ects the productive phase of viral infection. In HCIN and ICC, the transcription pattern was evenly distributed throughout the undierentiated epithelium with less signal intensity. In LCIN, cyclin A extended randomly through twothirds of the epithelial thickness, with higher levels on the lower epithelial half. In HCIN, cells were labelled randomly throughout the full thickness of the epithelium. In ICC, the cyclin A staining was seen throughout the tumour but its distribution was not always homogeneous ( Figure 1 , Table 2 ). In LCIN, p21 WAF1/CIP1 and p27 KIP1 were detected in the differentiated compartment as in normal mucosa. In HCIN, p21 WAF1/CIP1 was most often seen in the upper part of the mucosa but two cases showed p21 WAF1/CIP1 labelling predominantly in the intermediate part of the mucosa. Notably, although p27 KIP1 was also seen occasionally in the upper part of the mucosa it was always found in the basal cells except for one case. Such localization was never observed in normal mucosa and in only single basal cells of LCIN. In ICC, the expression of both CKIs usually resembled the one of cyclin A (Figure 1 , Figure 1 Single immunohistology of normal cervical epithelium, low grade/high grade cervical intra-epithelial neoplasia (L/HCIN), invasive cervical carcinoma (ICC) and condyloma acuminatum with antibodies against cyclin A, p21 WAF1/CIP1 and p27
. The staining intensity of positive nuclei varies from light to dark brown in bright-®eld microscopy. Nuclei of cells not expressing cyclin A, p21 WAF1/CIP1 or p27 KIP1 are stained blue by the counterstain. Original magni®cation6200 expressing compartments observed in normal cervix mucosa was disrupted in the cervical lesions (Figure 1 ).
Positive and negative cell cycle regulators co-localize in HPV 16-infected cells
From the experiments described above, it was clear that positive and negative cell cycle markers in CIN were observed in partly overlapping compartments.
In ICC, the detection pattern of these markers was similar in most cases. It was however not certain whether positive and negative cell cycle regulators were expressed in the same cells. Therefore, we performed cyclin A/p21 WAF1/CIP1 and cyclin A/p27 KIP1 double immuno¯uorescence of the specimens described above (Table 1) . There was no overlapping in normal epithelium as expected (data not shown).
In the lesions, the double staining revealed three dierent cell populations; those that were positive for cyclin A, those that were positive for either CKI, and those that showed a simultaneous expression of cyclin A and either CKI (Figures 3  and 4 ). The double labelling index is summarized in Table 4 . In LCIN, the cyclin A/p21
coexpression was signi®cantly higher than in HCIN (P50.00005) and ICC (P50.00005); moreover, cyclin A co-localized signi®cantly more with p21 WAF1/CIP1 than with p27 KIP1 (P=0.0002). The coexpression of cyclin A and p21 WAF1/CIP1 in LCIN was most pronounced in the middle part of the epithelium where dierentiation is still observed to occur. In HCIN and ICC, cyclin A co-localized equally but rarely with both CKIs. This colocalization was seen in the upper epithelial half in HCIN. These data demonstrate that the coexpression of positive and negative cell cycle regulators does occur in cervical lesions suggesting that the CKIs can be overcome by HPV 16. The WAF1/CIP1 could still be blocked in a non-proliferating state. (ii) Alternatively, the HPV 16 proteins bypass the inhibitory activity of p21 WAF1/CIP1 and cells have the ability to progress through the cell cycle. To discriminate between these two hypothesis, we checked the level of cyclin A during the cell cycle in CaSki cells, which are derived from a HPV 16-positive cervical carcinoma. CaSki cells were synchronized by a thymidine/aphidicolin double block, which arrests the cells at the beginning of S phase. At this point, the cells still have a DNA content of 2n, but after the release of the cell block, they rapidly start DNA replication. As shown in Figure 5 , cyclin A starts to be degraded 10.5 h after the block release, when the cells begin to enter G1 phase, and it is absent after 16 h, when most of the cells are in G1 phase. These results indicate that the cyclin A expression is not altered during the cell cycle in HPV 16-transformed cells. A similar conclusion was reached in two previous independent studies on the analysis of cell cycle regulation in HeLa cells, which are derived from a HPV 18-positive cervical carcinoma (Pagano et al., 1992; Pines and Hunter, 1990) .
To further con®rm the data as described above, which indicate that a fraction of the p21 WAF1/CIP1 -positive cells in HPV 16-infected tissue retains the ability to cycle, we performed Ki67/p21 WAF1/CIP1 double immuno¯uorescence of the specimens listed in Table 1 . Ki67 was chosen since it is considered to be one of the most reliable markers to assess cellular proliferation. The Ki67/p21 WAF1/CIP1 staining showed, as in the case of cyclin A, that a signi®cant proportion of the cells in LCIN co-expresses both cell cycle markers (Figure 6 ). In normal mucosa, HCIN and ICC, the pattern of Ki67/p21 WAF1/CIP1 staining was very similar to that of cyclin A/p21 WAF1/CIP1 (data not shown). Together, these data demonstrate that the coexpression of positive and negative cell cycle , 1996) . However, in vivo, this event was much more evident for p21 WAF1/CIP1 than for p27 and mainly con®ned to LCIN.
HPV 6-infected condyloma acuminatum has a staining pattern analogous to LCIN The data described above suggest that HPV 16-infected cells have the ability to pass through G1/S transition even in the presence of high levels of CKIs, especially p21 WAF1/ CIP1 . In order to determine whether the ability of HPV to bypass the CKIs is independent of the neutralization of the pocket protein pathway by E7, we also analysed HPV 6-infected condylomata acuminata (n=4) ( Table 1 ). In vitro data have shown that E7 of low risk HPVs binds the pocket protein pRB very ineciently . Co-expression of positive and negative cell cycle regulators in the same cell should be observed much less or not at all in HPV 6-infected condyloma acuminatum if such event were linked to the ability of the E7 protein to inactivate the pocket proteins. Immunohistology with the above markers showed that the expression of cyclin A and both CKIs in relation to normal mucosa was signi®cantly increased with regard to cyclin A (P=0.04) and p27 KIP1 (P=0.03) and insigni®cantly with regard to p21 WAF1/CIP1 (P=0.1) (Figures 1 and 7, Table 3 ). When employing double immuno¯uorescence as described above, the coexpression of cyclin A and p21 WAF1/CIP1 was similar to the one observed in LCIN, i.e. it was signi®cantly more pronounced in condyloma acuminatum than in HCIN (P=0.003) and ICC (P=0.001). Again, cyclin A colocalized signi®cantly more with p21 WAF1/CIP1 than with p27 KIP1 (P=0.01) (Figure 7 , Table 4 ). Also in condyloma acuminatum, as in the case of LCIN, the Ki67/p21 WAF1/CIP1 staining showed that in a fraction of cells both proteins were co-localized (Figure 8 ). These ®ndings suggest that the CKI overriding is not linked to the pocket protein (pRB) inactivation.
Discussion
The demonstration of cyclin A/p21 WAF1/CIP1 co-expression in the same cells provides strong evidence that the p21 WAF1/CIP1 G1 block can be overcome in HPV-infected cells in vivo. This conclusion is further strengthened by the fact that: (i) cyclin A was never found expressed during the G1 phase of cervical carcinoma-derived cell lines; and (ii) Ki67, an additional marker of proliferation, also co-localized with p21 WAF1/CIP1 in virtually the same percentage of cells in LCIN and condyloma acuminatum. Thus, the cyclin A/p21 WAF1/CIP1 -positive cells have the ability to progress into S phase despite high levels of p21 WAF1/CIP1 . In vitro studies have shown that the HPV 16 E7 protein can neutralize the inhibitory action of the cell cycle-regulating proteins p21 WAF1/CIP1 and p27 KIP1 (Funk et al., 1997; Jones et al., 1997; Zerfass-Thome et al., 1996; Blanton et al., 1992; Cheng et al., 1995) . Therefore, it is likely that our in vivo observations are due to the biological activity of E7. In support of this, we found that early viral message E6/E7 was con®ned to the same dierentiating compartment of LCIN where the cyclin A/p21 coexpression occurred (Figure 2) . Surprisingly, p27 KIP1 showed much less overlapping with cyclin A than p21 WAF1/CIP1 in LCIN and condyloma acuminatum suggesting that the p27 KIP1 neutralization does not play as important a role as p21 WAF1/CIP1 in HPV-infected squamous epithelium. This might be explained by the diverse functions of these proteins during epithelial maturation. Consistent with this reasoning is the observation that p21 WAF1/CIP1 occurs in the lower layers and p27 KIP1 in the upper layers of the dierentiating compartment. Interestingly, this cyclin A/p21 WAF1/CIP1 co-expression was mainly observed in LCIN. Moreover, it was similarly present in HPV 6-infected condyloma acuminatum, a benign lesion that virtually never develops into malignancy, despite its high proliferating ability.
The most likely explanation for the observed coexpression of cyclin A and p21 WAF1/CIP1 in LCIN and condyloma acuminatum is that the p21 WAF1/CIP1 inactivation by HPV may be involved in promoting the viral episomal DNA replication. Indeed, the productive life cycle of HPVs is tightly coupled to lesions in which the dierentiation program is still largely retained, e.g. LCIN and condyloma acuminatum (DuÈ rst et al., 1992) . This may explain why the cyclin A/p21 WAF1/CIP1 co-expression was mainly seen in LCIN and condyloma acuminatum but much less in HCIN and ICC. Furthermore, this process appears to be an early event in a productive HPV infection.
Considering earlier studies, two models can be proposed for p21 WAF1/CIP1 neutralization by HPVs. The ) nucleic staining. Nuclei expressing both proteins in the same cell appear in the range from yellow to orange. Original magni®cation6200
Overriding of CDKs by HPVs I Zehbe et al p21 WAF1/CIP1 inactivation by the viral oncoprotein could be indirectly mediated. In such a scenario, the E7 binding to pRB would activate E2F and trigger the synthesis of the cyclins E and A. The elevated levels of these cyclins would titrate the increase of p21 WAF1/CIP1 thus allowing the G1/S progression (Ruesch et al., 1997) . Alternatively, E7 may act directly through the interaction with p21 WAF1/CIP1 (Funk et al., 1997; Jones et al., 1997). In this study, we demonstrate that the ability to override the p21 WAF1/CIP1 -induced G1/S block is not necessarily linked to the inactivation eciency of the pocket proteins by E7. In support of the second model, we found a similar percentage of cells co-expressing p21 WAF1/CIP1 and cyclin A in HPV 16-and HPV 6-positive lesions. This may indicate that the virus has a direct eect on p21 WAF1/CIP1 independent of the eciency of E7 binding to pRB.
The level of both CKIs were usually higher in the tested lesions compared to those in normal mucosa. In a physiological environment, both CKIs have the ability to arrest the cell in G1 thus preventing further division cycles and enabling dierentiation. Recent data have also shown a novel inhibitory role of p21 WAF1/CIP1 in the late stage of dierentiation which is independent of its eects on the cell cycle (Di Cunto et al., 1998) . In fact, p21 WAF1/CIP1 degradation via the proteasome-dependent pathway is an essential requirement in determining keratinocyte terminal differentiation (Di Cunto et al., 1998) . What might be the reason(s) for CKI overexpression in cervical lesions? It has recently been shown that viral infections can induce a general host cell reaction through the action of interferon g, known to activate the p21 WAF1/CIP1 and p27 KIP1 pathway (Mandal et al., 1998) . The same study demonstrated that interferon a activates only p21 WAF1/ CIP1 . The p21 WAF1/CIP1 accumulation may also be induced by the activation of alternative pathways. For instance, it was demonstrated that the p21 WAF1/CIP1 gene is regulated by the transcription factor E2F, which is normally activated in HPV-infected cells (Hiyama et al., 1998) . Another possibility would be the transactivation pathway through p53 (Macleod et al., 1995) . The p21 WAF1/CIP1 overexpression of LCIN and possibly also of HCIN appeared to be p53-independent as p53 was observed only in a few cells. This is in keeping with the data that p53 is inactivated by the oncoprotein E6 of high risk HPV (Schener et al., 1990) . However, in ICC p53 appeared to be accumulated throughout the tumour similar to p21 WAF1/CIP1 (Zehbe et al., in preparation) . It remains to be shown whether p53 and p21 WAF1/CIP1 are co-expressed in the same cells. Likewise, the the role of other possible transactivators for the induction of p21 WAF1/CIP1 such as p73 and C/ EBPb needs still to be elucidated (Kaghad et al., 1997; Chinery et al., 1997) . However, the present evidence suggests that the overexpression of both p21 WAF1/CIP1 and p27 KIP1 in HPV-positive lesions may be related to either host cell defence or to an alteration of the dierentiation program.
In conclusion, we provide in vivo evidence that the CKIs, especially p21 WAF1/CIP1 can be overridden by HPVs, most likely by the oncoprotein E7. The ability of HPV to bypass the CKI functions appears to play a major role in the regulation of the viral life cycle, rather than in the induction of unscheduled proliferation alone. This is underlined by the fact that the bypassing of p21 WAF1/CIP1 was mostly found in lesions where the viral life cycle is completed. We also show that both low and high risk HPVs have the same ability to overcome p21
. Thus the bypassing of p21
WAF1/CIP1 appears not to be sucient for malignant transformation of the host cell. High risk HPVs probably possess additional mechanisms for the induction of proliferation, one of which probably involves the inactivation of the pocket proteins.
Materials and methods

Tissue samples
Forty-®ve formalin-®xed and paran-embedded specimens taken from Swedish women with various symptoms were obtained from the Pathology Department, University Hospital, Uppsala, Sweden. The histopathological diagnosis was obtained from hematoxylin and eosin-stained sections. All samples were previously HPV-tested by hot start polymerase chain reaction (PCR) with consensus primers from the L1 region and typed with single-strand conformation polymorphism (Zehbe et al., , 1997 .
RNA : RNA in situ hybridization
Serial sections of 4 ± 6 mm were mounted on positively charged slides (SuperFrost Plus, Menzel-GlaÈ ser, Braunschweig, Germany). The sections were deparanized, rehydrated in graded ethanols, digested with proteinase K (200 mg/ml) for 10 min at 378C, and hybridized with a pool of strand-speci®c RNA probes spanning the HPV 16 E6 and E7 open reading frames: base pairs 100 ± 217, 404 ± 521 and 528 ± 645. Brie¯y, radioactively labelled RNA probes were generated in the transcription vector pBluescript (Stratagene, La Jolla CA, USA) using T3 and T7 RNA polymerase, 100 mCi of 32 P-UTP (800 Ci/mmol, Amersham, Braunschweig, Germany), and 0.25 mM of each remaining precursor as cold substrate. This yielded an RNA with a speci®c activity of 10 9 c.p.m./mg. After DNase treatment, the probes were subjected to limited alkaline hydrolysis. ) nucleic staining. Nuclei expressing both proteins in the same cell appear in the range from yellow to orange. Original magni®cation6200
Hybridization was performed overnight at 428C in a solution containing 50% formamide, 26SSPE, 10% w/v dextran sulphate, 10 mM Tris, pH 7.5, 16Denhardt's solution, 500 mg/ml tRNA, 100 mg/ml sonicated herring sperm DNA (Promega, Heidelberg, Germany), 0.1% SDS, and 10 5 c.p.m. probe/ml approximately equalling a Tm of 725 to 7308C. Post hybridization was performed in a solution containing 50% formamide, 26SSPE, 0.1% SDS for 30 min at 508C, treated with RNase A (50 mg/ml) for 30 min at 378C, and subsequently washed in 50% formamide, 0.16SSC, 0.1% SDS for 30 min at 378C (Tm 710 to 7158C). Slides were dehydrated in graded ethanols containing 300 mM ammonium acetate, dried, and dipped in Kodak NTB 2 emulsion diluted 1 : 1 in 600 mM ammonium acetate. After 14 days exposure, the slides were developed in Kodak D-19 developer, ®xed, counterstained with H&E, and coverslipped.
Immunohistological staining
Sectioning was performed as above and sections were unmasked with target unmasking¯uid (TUF, Kreatech, Amsterdam, The Netherlands) or with 10 mM sodium citrate buer, pH 6 in a table autoclave at 1 bar for 10 min. This was followed by quenching endogenous peroxidase activity in 3% hydrogen peroxide for 5 min and incubation with blocking solution, i.e. normal goat serum in PBS (1 : 5 dilution) for 20 min, both at room temperature. Primary antibodies were incubated at optimized titrations in PBS/0.1% bovine serum albumin fraction V overnight at 48C. The polyclonal rabbit anticyclin A, (kindly provided by Dr J Pines, Wellcome/CRC Institute, Cambridge, UK), generated against the full length protein was diluted 1 : 1000. p21
(clone OP64, Oncogene Science, Cambridge, MA, USA), generated against the epitope comprising amino acids 58 ± 77 of human WAF1/CIP1 and p27 KIP1 (clone 57, Transduction Laboratories, Lexington, KY, USA), raised against the full length KIP1 protein were both diluted 1 : 100. Amplification of the primary antiserum was performed with biotinylated goat antimouse/antirabbit antiserum (1 : 200 ± 1 : 500 dilution) followed by streptavidin and biotinylated horseradish peroxidase complex (1 : 200 dilution) (StreptAB-Complex/HRP-Duet kit, DAKO, Hamburg, Germany) for 30 min each at room temperature. For chromogenic visualization, 3 (3)-diaminobenzidine-0.004% hydrogen peroxide substrate solution was used and brief counterstaining performed with Mayer's hematoxylin. Staining, which aected cell nuclei, was absent when the primary antibody was omitted. Slides were photographed with a Leica camera attached to a Leitz DMRBE microscope and processed with Adobe Photoshop 5.0.
Double immuno¯uorescence
Primary antisera were applied as above. Two antibodies, one monoclonal and one polyclonal, were always applied simultaneously. Secondary antisera were goat antimouseCy3 and goat antirabbit-¯uorescence isothiocyanite (Dianova, Hamburg, Germany), both diluted 1 : 200 and incubated for 60 min at room temperature. The addition of BSA was omitted. No nuclear counterstaining was performed. Objects were photographed with a Hamamatsu Color Chilled 3 CCD (C5810) camera attached to a Zeiss Axioplan microscope and processed with Adobe Photoshop 5.0.
Scoring of immunoreactive cells
For single immunohistology, the number of single labelled nuclei in 500 ± 1000 cells of the full-thickness epithelium in condyloma acuminatum and CIN as well as in 500 ± 1000 tumour cells of ICC was calculated in relation to unstained cells. For double immuno¯uorescence, an equal amount of cells was calculated with regard to double labelled nuclei in relation to cells expressing singly either cyclin A, p21 WAF1/CIP1 or p27 KIP1 .
Statistical analysis
The one and two sample t-test (Welsh-test) was used for statistical analysis of signi®cance. A P value of 50.05 was considered to be signi®cant.
Cell culture manipulation
CaSki cells were cultured in DMEM, supplemented with 10% foetal calf serum. They were synchronized by the thymidine/aphidicolin block at the beginning of S phase as described in detail above. Brie¯y, 10 6 cells were plated on 100 mm plates. After 24 h, thymidin was added at a ®nal concentration of 2.5 mM. After another 24 h, the cell cycle block was released by several washings in serum-free DMEM, followed by the addition of DMEM supplemented with 10% foetal calf cerum. After 12 h, aphidicolin was added at a ®nal concentration of 5 mg/ml. The second S phase block was released as described above. Cells at dierent phases of the cell cycle were collected for the FACS and immunoblotting analysis.
Immunoblotting analysis
For immunoblotting, cell extracts were prepared as earlier described (Tommasino et al., 1993) . Brie¯y, 30 mg of the cell extracts were applied to a SDS polyacrylamide gel and transferred to a PVDF membrane (DuPont, Boston, MA, USA). The cyclin A protein was detected with a polyclonal rabbit anti-cyclin A antibody at a dilution of 1 : 2000. This antibody was earlier used for the immunohistological staining.
